tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Immunome, Inc. (IMNM)
NASDAQ:IMNM
US Market
IMNM
Immunome
RESEARCH TOOLSreports

Immunome (IMNM) Stock News & Sentiment

Compare
394 Followers
Immunome Announces Follow-On Public Offering Pricing
Premium
Company Announcements
Immunome Announces Follow-On Public Offering Pricing
9d ago
8K
IMNM
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
11d ago
IMNM
KYTX
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
Premium
Ratings
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
11d ago
IMNM
Here’s Why Immunome Stock (IMNM) Soared Over 20% Today
Premium
Market News
Here’s Why Immunome Stock (IMNM) Soared Over 20% Today
11d ago
IMNM
Immunome’s Varegacestat Shines in Phase 3 RINGSIDE Trial, Earning Buy Rating from Charles Zhu
Premium
Ratings
Immunome’s Varegacestat Shines in Phase 3 RINGSIDE Trial, Earning Buy Rating from Charles Zhu
12d ago
IMNM
Immunome Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Immunome Announces Positive Phase 3 Trial Results
12d ago
8K
IMNM
Immunome’s Strategic Clinical Advancements and Financial Alignment Justify Buy Rating
Premium
Ratings
Immunome’s Strategic Clinical Advancements and Financial Alignment Justify Buy Rating
2M ago
IMNM
More IMNM News >

IMNM News on the Web

Why Immunome, Inc.’s (IMNM) Stock Is Up 5.31%
AAII
Neutral
Immunome's $400 Million Public Offering Draws Focus to Cancer Therapy Pipeline and Investor Demand
Market Chameleon
Neutral
Why Immunome, Inc.’s (IMNM) Stock Is Down 8.37%
AAII
Neutral
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
TipRanks News
Neutral
Stocks making the biggest moves midday: Zillow, KLA, iRobot, Immunome & more
CNBC
Neutral
Here’s Why Immunome Stock (IMNM) Soared Over 20% Today
TipRanks News
Neutral
Immunome to Reveal Pivotal Phase 3 Results for Varegacestat in Desmoid Tumors—What’s at Stake?
Market Chameleon
Neutral
Immunome’s Varegacestat Delivers Landmark Efficacy in Phase 3 RINGSIDE Trial for Desmoid Tumors
Market Chameleon
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMNM’s Media Buzz Sentiment?
Currently, no data Available
What is IMNM’s weekly average amount of articles?
Currently, no data Available
What is IMNM’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
DVAXDynavax
AGIOAgios Pharma
ADUSAddus Homecare
PDEXPro-Dex
ENSGThe Ensign Group
Showing the stocks with the most bullish news sentiment over the past week